PT  - JOURNAL ARTICLE
AU  - Duarte, Nathan
AU  - Arora, Rahul K.
AU  - Bennett, Graham
AU  - Wang, Meng
AU  - Snyder, Michael P.
AU  - Cooperstock, Jeremy R.
AU  - Wagner, Caroline E.
TI  - Deploying wearable sensors for pandemic mitigation
AID  - 10.1101/2022.02.07.22270634
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.02.07.22270634
4099  - http://medrxiv.org/content/early/2022/02/10/2022.02.07.22270634.short
4100  - http://medrxiv.org/content/early/2022/02/10/2022.02.07.22270634.full
AB  - Wearable sensors can continuously and passively detect potential respiratory infections, before or absent symptoms. However, the population-level impact of deploying these devices during pandemics is unclear. We built a compartmental model of Canada’s second COVID-19 wave and simulated wearable sensor deployment scenarios, systematically varying detection algorithm accuracy, uptake, and adherence. With current detection algorithms and 4% uptake, we found that deploying wearable sensors could have averted 9% of second wave SARS-CoV-2 infections, though 29% of this reduction is attributed to incorrectly quarantining uninfected device users. Improving detection specificity and offering confirmatory rapid tests each minimized incorrect quarantines and associated costs. With a sufficiently low false positive rate, increasing uptake and adherence became effective strategies for scaling averted infections. We concluded that wearable sensor deployment can meaningfully contribute to pandemic mitigation; in the case of COVID-19, technology improvements or supporting measures are required to reduce social and economic costs to acceptable levels.Competing Interest StatementMPS is a co-founder and member of the scientific advisory board of Personalis, Qbio, January, SensOmics, Protos, Mirvie, Fodsel, and Onza. He is also on the scientific advisory board of Danaher, Genapsys and Jupiter.Funding StatementThis study was author initiated and did not receive formal funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.